Status: Recruiting
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.
Participants needed: 15
Trial details
Biological sex: AllType: ObservationalSponsor: Aura BiosciencesUpdated: Feb 19, 2026Locations: 1
Eligibility criteria
Have enrolled in the Aura-sponsored clinical trial AU-011-301. [+1]
None